135 related articles for article (PubMed ID: 7731028)
1. The effect of serial passage on Sabin oral poliomyelitis vaccine virus in secondary monkey kidney versus Vero cells as measured by the monkey neurovirulence test.
Dommann CJ
J Med Primatol; 1994 Sep; 23(7):388-92. PubMed ID: 7731028
[TBL] [Abstract][Full Text] [Related]
2. Genetic stability and mutant selection in Sabin 2 strain of oral poliovirus vaccine grown under different cell culture conditions.
Taffs RE; Chumakov KM; Rezapkin GV; Lu Z; Douthitt M; Dragunsky EM; Levenbook IS
Virology; 1995 Jun; 209(2):366-73. PubMed ID: 7778271
[TBL] [Abstract][Full Text] [Related]
3. Microevolution of Sabin 1 strain in vitro and genetic stability of oral poliovirus vaccine.
Rezapkin GV; Chumakov KM; Lu Z; Ran Y; Dragunsky EM; Levenbook IS
Virology; 1994 Jul; 202(1):370-8. PubMed ID: 8009849
[TBL] [Abstract][Full Text] [Related]
4. Genetic stability of oral polio vaccine prepared on primary monkey kidney cells or Vero cells--effects of passage in cell culture and the human gastrointestinal tract.
Chezzi C; Dommann CJ; Blackburn NK; Maselesele E; McAnerney J; Schoub BD
Vaccine; 1998 Dec; 16(20):2031-8. PubMed ID: 9796061
[TBL] [Abstract][Full Text] [Related]
5. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
[TBL] [Abstract][Full Text] [Related]
6. Microevolution of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control.
Rezapkin GV; Norwood LP; Taffs RE; Dragunsky EM; Levenbook IS; Chumakov KM
Virology; 1995 Aug; 211(2):377-84. PubMed ID: 7645242
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the accumulation of mutants in Sabin attenuated polio vaccine viruses passaged in Vero cells.
Horie H; Miyazawa M; Ota Y; Wakabayashi K; Yoshida H; Doi Y; Hashizume S
Vaccine; 2001 Jan; 19(11-12):1456-9. PubMed ID: 11163668
[TBL] [Abstract][Full Text] [Related]
8. An infectious cDNA clone of the poliovirus Sabin strain could be used as a stable repository and inoculum for the oral polio live vaccine.
Kohara M; Abe S; Kuge S; Semler BL; Komatsu T; Arita M; Itoh H; Nomoto A
Virology; 1986 May; 151(1):21-30. PubMed ID: 3008430
[TBL] [Abstract][Full Text] [Related]
9. Some aspects of the monkey neurovirulence test used for the assessment of oral poliovirus vaccines.
Furesz J; Contreras G
Dev Biol Stand; 1993; 78():61-70. PubMed ID: 8388832
[TBL] [Abstract][Full Text] [Related]
10. Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication.
Macadam AJ; Ferguson G; Stone DM; Meredith J; Knowlson S; Auda G; Almond JW; Minor PD
J Virol; 2006 Sep; 80(17):8653-63. PubMed ID: 16912313
[TBL] [Abstract][Full Text] [Related]
11. Production of high titer attenuated poliovirus strains on the serum-free PER.C6(®) cell culture platform for the generation of safe and affordable next generation IPV.
Sanders BP; Oakes Ide L; van Hoek V; Liu Y; Marissen W; Minor PD; Wimmer E; Schuitemaker H; Custers JH; Macadam A; Cello J; Edo-Matas D
Vaccine; 2015 Nov; 33(48):6611-6. PubMed ID: 26529068
[TBL] [Abstract][Full Text] [Related]
12. Genetic characterization of Sabin types 1 and 3 poliovaccine virus following serial passage in the human intestinal tract.
Contreras G; Dimock K; Furesz J; Gardell C; Hazlett D; Karpinski K; McCorkle G; Wu L
Biologicals; 1992 Mar; 20(1):15-26. PubMed ID: 1319179
[TBL] [Abstract][Full Text] [Related]
13. Significance of a newly identified attenuating mutation in Sabin 3 oral poliovirus vaccine.
Mento SJ; Weeks-Levy C; Tatem JM; Gorgacz EJ; Waterfield WF
Dev Biol Stand; 1993; 78():93-9; discussion 99-100. PubMed ID: 8388835
[TBL] [Abstract][Full Text] [Related]
14. Non-neurovirulent, genetically stable clone of poliovirus (Sabin type III vaccine strain).
Ubertini TR; Cioni C; Perini L; Gagnoni S
Vaccine; 1988 Dec; 6(6):481-2. PubMed ID: 2854337
[TBL] [Abstract][Full Text] [Related]
15. Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus.
Georgescu MM; Tardy-Panit M; Guillot S; Crainic R; Delpeyroux F
J Virol; 1995 Sep; 69(9):5278-86. PubMed ID: 7636970
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of poliovirus excretion after vaccination of infants with two oral polio vaccines prepared on Vero cells or on primary monkey kidney cells.
Mallet L; Pelloquin F; Brigaud M; Caudrelier P; Bandet R; Xueref C; Fuchs F; Gibelin N; Goldman C; Moulin JC; de Fraipont F; Montagnon B; Peyron L; Aymard M
J Med Virol; 1997 May; 52(1):50-60. PubMed ID: 9131458
[TBL] [Abstract][Full Text] [Related]
17. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome.
Evans DM; Dunn G; Minor PD; Schild GC; Cann AJ; Stanway G; Almond JW; Currey K; Maizel JV
Nature; 1985 Apr 11-17; 314(6011):548-50. PubMed ID: 2986004
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the genetic stability of Sabin strains and the consistency of inactivated poliomyelitis vaccine made from Sabin strains using direct deep-sequencing.
Deng Y; Cai W; Li J; Li Y; Yang X; Ma Y; Yao Y; Yang L; Shi L; Sun M
Vaccine; 2019 Jan; 37(1):130-136. PubMed ID: 30467062
[TBL] [Abstract][Full Text] [Related]
19. Studies on neurovirulence in poliovirus-sensitive transgenic mice and cynomolgus monkeys for the different temperature-sensitive viruses derived from the Sabin type 3 virus.
Abe S; Ota Y; Doi Y; Nomoto A; Nomura T; Chumakov KM; Hashizume S
Virology; 1995 Jun; 210(1):160-6. PubMed ID: 7793068
[TBL] [Abstract][Full Text] [Related]
20. Preliminary studies on the neurovirulence of poliomyelitis vaccine (oral) prepared in vero cells.
Guo R; Chen SF; Luo GX; Luo QS; Xu QF
Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(2):104-7. PubMed ID: 2848237
[No Abstract] [Full Text] [Related]
[Next] [New Search]
